Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW815SF HFA MDI vs Salmeterol + Fluticasone DPI in Pediatric Asthma
NCT00448435Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2007
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol + fluticasone propionate in asthma, sponsored by GSK. Started Apr 2007; status: completed.
02
Drugs
salmeterol + fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00448435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448435.